Forty-eight-week safety of bimekizumab in psoriasis: focus on infectious comorbidities

Authors

Institutions

Publication Details

Journal
Italian Journal of Dermatology and Venereology
Published
2025-12-11
DOI
https://doi.org/10.23736/s2784-8671.25.08398-7
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Forty-eight-week safety of bimekizumab in psoriasis: focus on infectious comorbidities

Alberta Bettacchi, Emanuele Trovato, Tommaso Bianchelli, Anna Campanati et al.
Italian Journal of Dermatology and Venereology
Psoriasis: Treatment and Pathogenesis
article

Forty-eight-week safety of bimekizumab in psoriasis: focus on infectious comorbidities

Alberta Bettacchi, Emanuele Trovato, Tommaso Bianchelli, Anna Campanati, Aldo Cuccia, Paolo ROMITA, Valentina Dini, Gionata Buggiani, Francesca Prignano, Ganzetti Giulia
article en

Abstract

No abstract available for this paper.
Italian Journal of Dermatology and VenereologyVol. 161(1)
University of Siena (IT), University of Pisa (IT), Marche Polytechnic University (IT), Carle Foundation Hospital (US), Ospedale San Donato (IT), Ospedale San Giuseppe (IT), Istituto Nazionale di Riposo e Cura per Anziani (IT), University of Florence (IT), University of Macerata (IT), University of Bari Aldo Moro (IT)
Openalex Percentile: Top 55%
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.